Tsukuba, Japan

Hiroshi Miyazoe


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):

Title: Hiroshi Miyazoe: Innovator in Medicinal Chemistry

Introduction

Hiroshi Miyazoe is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on cycloalkanopyridine derivatives. His research focuses on developing compounds that can serve as effective treatments for various medical conditions.

Latest Patents

Miyazoe holds a patent for a cycloalkanopyridine derivative, which is described by the formula [I]. The compounds he has developed act as nociceptin receptor antagonists. These derivatives are useful in treating diseases associated with the nociceptin receptor, including relief from tolerance to narcotic analgesics, dependence on narcotic analgesics, and cognitive impairments. His work also addresses conditions such as schizophrenia, neurodegenerative diseases, and diabetes insipidus.

Career Highlights

Hiroshi Miyazoe is affiliated with Banyu Pharmaceutical Co. Ltd., where he continues to advance his research in medicinal chemistry. His innovative approach has led to the development of compounds that have the potential to improve patient outcomes in various therapeutic areas. With 1 patent to his name, he exemplifies the spirit of innovation in the pharmaceutical industry.

Collaborations

Miyazoe has collaborated with notable colleagues, including Hirobumi Takahashi and Yuichi Sugimoto. These partnerships have fostered a collaborative environment that enhances the research and development of new medicinal compounds.

Conclusion

Hiroshi Miyazoe's contributions to medicinal chemistry through his innovative patents highlight the importance of research in developing new treatments for complex medical conditions. His work continues to inspire advancements in the pharmaceutical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…